In adults, the condition is most commonly diagnosed either in a person’s 20s or after age 50 ... skin changes before you have entered menopause. When you have eczema, your skin is especially ...

As Sanofi anticipates sales of immunotherapy juggernaut Dupixent reaching a major $22 billion by the end of the decade, ...

The FDA has approved the popular drug Dupixent (generic name, dupilumab) for adults and kids 12 and up with chronic spontaneous urticaria (CSU), a long-lasting itchy skin condition, when regular ...

Sanofi and Regeneron's eczema injection Dupixent looks set for approval later this year after the release of further ... treatment Eucrisa was approved before Christmas – a significant ...

Sanofi’s Dupixent (dupilumab) has been cleared for NHS funding in Wales and Scotland in adolescents with severe eczema ... SMC’s decision came a few days after the AWMSG also okayed Dupixent ...

Birthmarks are colored skin spots that either are present at birth or develop shortly after birth ... FDA Approves Dupixent for Chronic Skin ConditionThe FDA has approved the popular drug Dupixent ...